WAT – Waters Corporation

Waters Corporation

WAT

$324.34

Name : Waters Corporation

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $19,269,480,448.00

EPSttm : 10.7

Waters Corporation

$324.34

6.02%

$20.78

Float Short %

2.51

Margin Of Safety %

Put/Call OI Ratio

0.41

EPS Next Q Diff

-1.18

EPS Last/This Y

2.12

EPS This/Next Y

1.33

Price

345.12

Target Price

411.22

Analyst Recom

2.46

Performance Q

-6.97

Relative Volume

2.13

Beta

1.13

Ticker: WAT

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-05	WAT	378.8	0.42	0.03	2182
2025-03-06	WAT	386.33	0.48	2.00	1996
2025-03-07	WAT	392.97	0.49	0.05	1998
2025-03-10	WAT	390.63	0.48	0.40	2008
2025-03-11	WAT	378.61	0.48	2.43	2010
2025-03-12	WAT	372.94	0.55	0.00	2171
2025-03-13	WAT	364.21	0.55	0.00	2176
2025-03-14	WAT	377.18	0.53	1.00	2165
2025-03-17	WAT	378.78	0.53	1.00	2165
2025-03-18	WAT	381.99	0.53	0.33	2164
2025-03-19	WAT	369.92	0.53	0.66	2168
2025-03-20	WAT	363.47	0.53	0.09	2225
2025-03-21	WAT	365.49	0.44	40.00	2397
2025-03-24	WAT	373.12	0.28	0.85	1148
2025-03-25	WAT	368.54	0.29	14.17	1182
2025-03-26	WAT	367.78	0.38	1.11	1270
2025-03-27	WAT	370.38	0.41	0.20	1384
2025-03-28	WAT	361.74	0.41	0.00	1387
2025-03-31	WAT	368.57	0.41	2.00	1393
2025-04-01	WAT	355.89	0.41	1.00	1396
2025-04-02	WAT	362.57	0.41	7.00	1398
2025-04-03	WAT	344.87	0.41	0.33	1404
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-05	WAT	378.87	0.9	111.5	12.87
2025-03-06	WAT	386.28	0.9	102.9	12.87
2025-03-07	WAT	392.89	0.9	100.7	12.87
2025-03-10	WAT	390.51	0.9	80.2	12.87
2025-03-11	WAT	378.13	0.9	66.2	12.87
2025-03-12	WAT	372.95	0.9	80.0	12.87
2025-03-13	WAT	364.44	0.9	73.2	12.87
2025-03-14	WAT	377.15	0.9	124.5	12.87
2025-03-17	WAT	378.92	0.9	97.9	12.87
2025-03-18	WAT	382.15	0.9	101.3	12.87
2025-03-19	WAT	371.34	0.9	68.7	12.87
2025-03-20	WAT	363.22	0.9	74.4	12.87
2025-03-21	WAT	365.78	0.9	100.0	12.87
2025-03-24	WAT	373.30	0.9	112.7	12.87
2025-03-25	WAT	368.53	0.9	82.5	12.87
2025-03-26	WAT	367.79	0.9	92.0	12.87
2025-03-27	WAT	370.38	0.9	100.0	12.87
2025-03-28	WAT	362.16	0.9	73.7	12.87
2025-03-31	WAT	368.57	0.9	109.4	12.87
2025-04-01	WAT	356.00	0.9	63.7	12.87
2025-04-02	WAT	362.64	0.9	110.2	12.87
2025-04-03	WAT	345.12	0.9	51.1	12.87
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-05	WAT	0.00	0.28	2.20
2025-03-06	WAT	0.00	0.28	2.20
2025-03-07	WAT	0.00	0.28	2.20
2025-03-10	WAT	0.00	0.58	2.20
2025-03-11	WAT	0.00	0.58	2.20
2025-03-12	WAT	0.00	0.58	2.73
2025-03-13	WAT	0.00	0.58	2.73
2025-03-14	WAT	0.00	0.58	2.73
2025-03-17	WAT	0.00	0.58	2.73
2025-03-18	WAT	0.00	0.58	2.73
2025-03-19	WAT	0.00	0.58	2.73
2025-03-20	WAT	0.00	0.58	2.73
2025-03-21	WAT	0.00	0.58	2.73
2025-03-24	WAT	0.00	0.61	2.73
2025-03-25	WAT	0.00	0.61	2.73
2025-03-26	WAT	0.00	0.61	2.51
2025-03-27	WAT	0.00	0.61	2.51
2025-03-28	WAT	0.00	0.61	2.51
2025-03-31	WAT	0.00	0.61	2.51
2025-04-01	WAT	0.00	0.61	2.51
2025-04-02	WAT	0.00	0.61	2.51
2025-04-03	WAT	0.00	0.61	2.51
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

4.1

Avg. EPS Est. Current Quarter

2.23

Avg. EPS Est. Next Quarter

2.92

Insider Transactions

Institutional Transactions

0.61

Beta

1.13

Average Sales Estimate Current Quarter

655

Average Sales Estimate Next Quarter

737

Fair Value

368.48

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

19.4

Max Drawdown 5-Year %

-44.3

Target Price

411.22

P/E

32.21

Forward P/E

24.32

PEG

3.26

P/S

6.93

P/B

11.21

P/Free Cash Flow

33.09

EPS

10.71

Average EPS Est. Cur. Y

12.87

EPS Next Y. (Est.)

14.19

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

21.56

Relative Volume

2.13

Return on Equity vs Sector %

15.1

Return on Equity vs Industry %

24.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

51.1

Waters Corporation

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 7600

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

stock quote shares WAT – Waters Corporation Stock Price stock today

news today WAT – Waters Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch WAT – Waters Corporation yahoo finance google finance

stock history WAT – Waters Corporation invest stock market

stock prices WAT premarket after hours

ticker WAT fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

WAT – Waters Corporation

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: WAT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y